​Post Authorization Safety Studies with Nancy Dreyer

Global approaches to post-approval safety are changing rapidly around the world. If you are bringing a new drug or device to market in Europe, you will want to know how companies are satisfying their post-authorization safety requirements. New pharmacovigilance regulations were implemented in Europe in 2012. IQVIA looked at what happened in the 3 years after implementation. Learn how IQVIA can help you navigate the challenges and the opportunities of this new era in Post-Authorization Safety Studies (PASS). TRT: 3:30

​Post Authorization Safety Studies with Nancy Dreyer

You may also be interested in
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.